荧光团
荧光
一级和二级抗体
共焦
染色
荧光寿命成像显微镜
自体荧光
显微镜
分子成像
共焦显微镜
生物医学工程
化学
材料科学
病理
抗体
医学
光学
体内
生物
物理
生物技术
免疫学
作者
Tarek Ashkar,Michael J. Ferkowicz
标识
DOI:10.17504/protocols.io.9avh2e6
摘要
Frozen participant samples are first sized and preserved for high-resolution 3D imaging. Preserved biopsy sections are imaged, without staining, to understand the sample’s structure and condition.Next, the biopsy sections are stained with antibodies and fluorescent dyes to identify specific structures and cells with pathological significance.This stained sample is imaged in its entirety giving a 3D image.Finally, the 3D image is analyzed by experts to assess known and novel pathologies. This protocol summarizes both label-free imaging and labeling for fluorescence imaging including the labeling, mounting and imaging approaches.The fluorescent labels used herein include conjugated or fluorescent small molecules and conjugated antibodies.Protocol 2 uses both directly conjugated primary antibodies for identifying specific antigens and indirect labeling with a fluorophore conjugated secondary antibody that recognizes the primary antibody. Multiple rounds of imaging are enabled by the use of a non-hardening mounting media, low charge slides and removable rubber cement as a sealant.Details are described below. Two imaging approaches are outlined: protocol 1 and 2.Protocol 1 involves label free imaging of auto-fluorescent species and second harmonic generation (SHG) with multiphoton excitation.These modalities are followed by protocol 2, which involves staining with fluorescent small molecules and immuno-fluorescence and subsequent large scale 3D confocal fluorescence imaging.There are three different staining strategies used in protocols, summarized in Table 1. These protocols start with fixed 50 µm tissue sections prepared as described in the Cryopreservation protocol.
科研通智能强力驱动
Strongly Powered by AbleSci AI